Drugs / Orcinoside
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02191384 | Jul 2014 → Mar 2016 | major depressive disorder | Shanghai Mental Health Center | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Orcinoside | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02191384 ↗ |
| Route | Oral | “oral, twice per day” NCT02191384 ↗ |